Prementrual dysphoric Disorder
Conditions
Interventions
expermential group:The auriculotherapy protocol strictly adhered to STRICTA guidelines. Participants allocated to the experimental group received active auricular acupressure (AA). Interventions comme
colltrol group:The control group received sham AA, with 5 non-therapeutic points selected (Eye, Teeth, Shoulder, Finger, External Nose) that are anatomically unrelated to emotional regulation pathways
Sponsors
School of Nursing, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Participants were included if they were college students aged 18-35 years with a confirmed PMDD diagnosis via the Chinese version of CTDP-DSM-5 (CTDP-C), a validated 25-item self-rating scale assessing symptoms over 12 months. Diagnosis required symptoms occurring in most menstrual cycles of the past year, dichotomous (yes/no) scoring indicating significant distress/functional impairment, and validation via a DSM-5-aligned algorithm. Eligible participants also had regular menstrual cycles (21-35 days) and access to internet-connected devices for study participation. CTDP-C has demonstrated good validity and reliability in Chinese PMDD populations.
Exclusion criteria
Exclusion criteria: Exclusion criteria included there are damages, infections, a history of allergies on the ear skin, or allergies to the materials used for auricular point sticking; Complicated with serious organic diseases of vital organs such as the heart, liver, and kidneys; In the pregnancy or lactation period; Currently/planning to be pregnant, breastfeeding, having comorbid mental illnesses that may confound the assessment of premenstrual dysphoric disorder (PMDD) (such as severe depression, bipolar disorder), having used psychotropic drugs or hormonal contraceptives in the past 3 months, having a history of psychiatric hospitalization, suicide attempts, or persistent alcohol/drug abuse; The participants received psychological therapy, drug therapy, or traditional Chinese medicine intervention during the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of depression and anxiety; | — |
Secondary
| Measure | Time frame |
|---|---|
| Brain activity recording based on electroencephalogram;Assessment of emotional state and social functioning; | — |
Countries
China
Contacts
Public ContactJunxiang Wang
School of Nursing, Beijing University of Chinese Medicine
Outcome results
None listed